⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL386774 | 0.73 | — | — | |
| SCHEMBL8862218 | 0.71 | — | — | |
| SCHEMBL2555223 | 0.71 | — | — | |
| SCHEMBL23878216 | 0.71 | — | — | |
| SCHEMBL387277 | 0.69 | — | — | |
| SCHEMBL1362975 | 0.69 | — | — | |
| SCHEMBL5956225 | 0.69 | — | — | |
| SCHEMBL2964898 | 0.67 | — | — | |
| SCHEMBL1454285 | 0.65 | — | — | |
| SCHEMBL2973662 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108299532-B | Antiviral nucleoside analogue prodrug and composition and application thereof | 广东东阳光药业有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-105980387-B | Serine/threonine kinase inhibitor | 阵列生物制药公司 | 2019-04-19 | — | — | CN | claimed |
| CN-108299532-A | A kind of antiviral nucleoside analogue prodrug and combinations thereof, purposes | 广东东阳光药业有限公司 | 2018-07-20 | — | — | CN | claimed |
| EP-3089980-B1 | SERINE/THREONINE KINASE INHIBITORS | ARRAY BIOPHARMA INC (US) | 2018-01-31 | — | — | EP | claimed |
| US-9670208-B2 | Serine/threonine kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2017-06-06 | — | — | US | claimed |
| EP-3089980-A1 | SERINE/THREONINE KINASE INHIBITORS | Array Biopharma, Inc. (US) | 2016-11-09 | — | — | EP | claimed |
| US-20160304519-A1 | SERINE/THREONINE KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2016-10-20 | — | — | US | claimed |
| CN-105980387-A | Serine/threonine kinase inhibitors | 阵列生物制药公司 | 2016-09-28 | — | — | CN | claimed |
| WO-2015103137-A1 | SERINE/THREONINE KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2015-07-09 | — | — | WO | claimed |
| US-8344142-B2 | perylenetetracarboxylic diimide core having side chains (groups or mesogens) attached to the core; to provide charge-transport materials having various volatilities, solubilities, crystallinity, and charge transport ability; organic light emitting diode; photovoltaic cells, light-emitting diodes | GEORGIA TECH RESEARCH CORPORATION (US) | 2013-01-01 | — | — | US | claimed |
| US-8039625-B2 | Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-10-18 | — | — | US | claimed |
| US-20090044863-A1 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | NATIONAL SCIENCE FOUNDATION | 2009-02-19 | — | — | US | claimed |
| US-20080223444-A1 | Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | GEORGIA TECH RESEARCH CORPORATION | 2008-09-18 | — | — | US | claimed |
| WO-2006093965-A2 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2006-09-08 | — | — | WO | claimed |
| WO-2005124453-A2 | PERYLENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2005-12-29 | — | — | WO | claimed |
| WO-2001080839-A2 | USE OF NAPHTHINDAZOLE-4,9-QUINONES AS ANTIPARASITIC AGENTS | BUNDESREPUBLIK DEUTSCHLAND vertreten durch das BUNDESMINISTERIUM FÜR GESUNDHEIT, dieses vertreten durch das ROBERT-KOCH-INSTITUT, vertreten durch seinen leiter (DE) | 2001-11-01 | — | — | WO | claimed |
| WO-2001080838-A2 | USE OF N2-SUBSTITUTED BENZ[F]INDAZOLE-4,9-QUINONES AS ANTIPARASITIC AGENTS | BUNDESREPUBLIK DEUTSCHLAND vertreten durch das BUNDESMINISTERIUM FÜR GESUNDHEIT, diesed vertreten durch das ROBERT-KOCH-INSTITUT, vertreten durch SEINEN LEITER (DE) | 2001-11-01 | — | — | WO | claimed |
| EP-0074511-B1 | 2H-1,2,4,6-THIATRIAZIN(3)ON-1,1 DIOXIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES | BASF Aktiengesellschaft (DE) | 1987-12-09 | — | — | EP | claimed |
| EP-0078462-B1 | 1,2,4,6-THIATRIAZINE-1,1 DIOXIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTI-GROWTH AGENTS FOR UNWANTED PLANTS | BASF Aktiengesellschaft (DE) | 1986-01-15 | — | — | EP | claimed |
| US-4316015-A | 6H-1,2,4,6-Thiatriazine-1,1-dioxides | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | claimed |